Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Akorn Inc (NASDAQ:AKRX)

22.08
Delayed Data
As of Feb 27
 +0.80 / +3.76%
Today’s Change
17.57
Today|||52-Week Range
35.40
+1.15%
Year-to-Date
SECTOR
Distribution Services
INDUSTRY
Medical Distributors
MARKET CAP
$2.8B

Company Description

Akorn, Inc. is a niche pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and consumer health products. It operates through the Prescription Pharmaceuticals and Consumer Health segments. The Prescription Pharmaceuticals segment engages in the sales of generic and branded prescription pharmaceuticals including ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. The Consumer Health segment engages in the sales of animal health and over-the-counter (OTC) products, both branded and private label. The company was founded in 1971 and is headquartered in Lake Forest, IL.

Contact Information

Akorn, Inc.
1925 West Field Court
Lake Forest Illinois 60045-4862
P:(847) 279-6100
Investor Relations:

Employees

Shareholders

Other institutional37.96%
Mutual fund holders35.98%
Individual stakeholders29.92%

Top Executives

Rajat RaiChief Executive Officer
Bruce KutinskyChief Operating Officer
Duane A. PortwoodCFO & Executive Vice President
Mark M. SilverbergExecutive VP-Operations & Technical Services
Joseph P. BonaccorsiSecretary, Senior Vice President & General Counsel